Transplant of Organs From SARS-CoV-2-Positive Donors Safe
Outcomes for hospital length of stay, 30-day mortality, 30-day graft loss similar for nucleic acid test-positive and -negative donors
Global Economic Cost of Cancer Estimated to Be $25.2 Trillion From 2020 to 2050
75.1 percent of cancer deaths occur in low-, middle-income countries, which account for 49.5 percent of economic cost
SBRT Well Tolerated, Effective for Primary Lung Neuroendocrine Tumor
At three, six, and nine years, overall survival was 64, 43, and 26 percent and progression-free survival was 88, 78, and 78 percent, respectively
Transcendental Meditation Helps to Alleviate Burnout in Academic Physicians
Benefits seen for total burnout, emotional exhaustion, and depression at four months
Remote Evaluation Feasible for Preoperative Bariatric Care
Patient outcomes, including surgical and follow-up, were similar to in-person evaluation
Omission of Radiotherapy After Breast-Conserving Surgery Explored
Increased incidence of local recurrence seen with omission of radiotherapy, but no effect seen on overall survival
Financial Toxicity From Breast Cancer Treatment Is Common
More than 30 percent of patients in high-income countries incur financial toxicity
Long-Term Outcomes Explored After Chronic Pancreatitis Surgery
Ten-year overall survival is 63.5 percent; only persistent opioid use associated with worse overall survival in multivariable modeling
Prior Paid Medical Malpractice Claims Predict Future Claims Risk
Findings independent of whether a physician is practicing in a high- or low-risk specialty
Positive Five-Year Outcomes Seen for Nivolumab in Resectable Lung Cancer
Eight of nine patients with major pathological response (MPR) were alive and disease-free at five years, while six of 11 without MPR experienced relapse
